Aerie Pharmaceuticals, Inc. (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other...
Read Story
May 03, 2019, 09:00 AM
|
Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced that it has entered into a definitive agreement to raise approximately $52 million gross cash proceeds through the issuance of approximately 7.9...
Read Story
April 01, 2019, 09:00 AM
|
Harvard University and Deerfield Management, a healthcare investment firm, have established a major strategic R&D alliance to speed the development and translation of biomedical and life-science innovations into transformative treatments that can...
Read Story
March 15, 2019, 06:00 AM
|
Adeptus Health Inc. announced that it has collaborated with Deerfield Management Company and certain of its other creditors on the terms of a comprehensive financial restructuring plan that is expected to significantly reduce the outstanding debt...
Read Story
April 21, 2017, 07:00 AM
|
New York hedge fund Deerfield Management, a healthcare-only investment firm with over $8.0 billion under management, has purchased outstanding bank debt from Adeptus Health, Inc., and expects to provide additional financing, along with operational...
Read Story
April 07, 2017, 07:09 AM
|
Deerfield Management Company announced that it has committed to provide up to $170 million to Endologix, Inc. in a combination of senior secured notes and a working capital facility. Endologix is a marketer and developer of innovative, minimally...
Read Story
April 06, 2017, 07:13 AM
|
Solar Capital Ltd. and Solar Senior Capital Ltd. announced that they have formed Solar Life Science Program LLC with Deerfield Management. Founded in 1994, Deerfield Management is a private investment firm with over $8 billion in assets under...
Read Story
February 23, 2017, 07:11 AM
|
Neos Therapeutics, Inc., a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products for the treatment of attention-deficit/hyperactivity disorder (ADHD),announced the closing of a $60 million term...
Read Story
May 16, 2016, 07:13 AM
|
Depomed, Inc. has entered into a definitive agreement with Deerfield and Pharmakon Advisors, LP to borrow $575 million. The proceeds of the loan will be used to fund the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen...
Read Story
March 13, 2015, 07:21 AM
|
Horizon Pharma, Inc. announced that it has entered into an agreement with a group of lenders to provide Horizon with $300 million in financing through a five year senior secured credit facility. Funding is expected to occur coincident with the...
Read Story
June 19, 2014, 07:33 AM
|
IMRIS Inc. announced it has entered into a secured loan facility agreement (the "Agreement") with Deerfield Management Company, L.P. ("Deerfield") for $25 million in financing. Deerfield is a leading healthcare investment firm with more than $3.5...
Read Story
September 18, 2013, 07:03 AM
|